Cellular transformation of NIH3T3 fibroblasts by CIZ/NMP4 fusions

Journal of Cellular Biochemistry

Volumn 94, Issue 6, 2005, Pages 1112-1125

  Corveleyn, Anniek ^a   Janssen, Hilde ^a   Martini, Alessandra ^a   Somers, Riet ^a   Cools, Jan ^a   Marynen, Peter ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cellular transformation; CIZ fusions; DNA binding; Structure function analysis; Transactivation

Indexed keywords

CIZ NMP4 FUSION PROTEIN; E2A CIZ FUSION PROTEIN; HYBRID PROTEIN; LUCIFERASE; MATRILYSIN; TAF15 CIZ FUSION PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VP16 CIZ FUSION PROTEIN; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL TRANSFORMATION; CHROMOSOME 12P; CHROMOSOME TRANSLOCATION; EWSR1 GENE; GENE EXPRESSION; GENE TARGETING; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; SOLID TUMOR; TAF15 GENE; TRANSACTIVATION;

ANIMALS; ARTIFICIAL GENE FUSION; BASE SEQUENCE; CELL LINE, TRANSFORMED; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE DELETION; HUMANS; MICE; MUTATION; NIH 3T3 CELLS; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PLASMIDS; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 26444495164     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20369     Document Type: Article

References (51)

1. Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B. 1999. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol 19:6085-6097.
2. Alvarez M, Long H, Onyia J, Hock J, Xu W, Bidwell J. 1997. Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter. Endocrinology 138:482-489.
3. Aronheim A, Shiran R, Rosen A, Walker MD. 1993. The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc Natl Acad Sci USA 90:8063-8067.
4. Arvand A, Denny CT. 2001. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20:5747-5754.
5. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G, Ghysdael J. 1994. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 14:3230-3241.
6. Barr FG, Fitzgerald JC, Ginsberg JP, Vanella ML, Davis RJ, Bennicelli JL. 1999. Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res 59:5443-5448.
7. Bertolotti A, Lutz Y, Heard DJ, Chambon P, Tora L. 1996. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 15:5022-5031.
8. Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O, Tora L. 1998. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: Interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol Cell Biol 18:1489-1497.
9. Bertolotti A, Bell B, Tora L. 1999. The N-terminal domain of human TAF(II)68 displays transactivation and oncogenic properties. Oncogene 18:8000-8010.
10. Bidwell JP, Torrungruang K, Alvarez M, Rhodes SJ, Shah R, Jones DR, Charoonpatrapong K, Hock JM, Watt AJ. 2001. Involvement of the nuclear matrix in the control of skeletal genes: The NMP1 (YY1), NMP2 (Cbfa1), and NMP4 (Nmp4/CIZ) transcription factors. Crit Rev Eukaryot Gene Expr 11:279-297.
11. Braun BS, Frieden R, Lessnick SL, May WA, Denny CT. 1995. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol 15:4623-4630.
12. Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, Hassell JA, Matrisian LM. 2001. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 21:1370-1383.
13. Deneen B, Denny CT. 2001. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene 20:6731-6741.
14. Feister HA, Torrungruang K, Thunyakitpisal P, Parker GE, Rhodes SJ, Bidwell JP. 2000. NP/NMP4 transcription factors have distinct osteoblast nuclear matrix subdomains. J Cell Biochem 79:506-517.
15. Fu X, Kamps MP. 1997. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol Cell Biol 17:1503-1512.
16. Fu X, Roberts WG, Nobile V, Shapiro R, Kamps MP. 1999. mAngiogenin-3, a target gene of oncoprotein E2a-Pbx1, encodes a new angiogenic member of the angiogenin family. Growth Factors 17:125-137.
17. Fuchs B, Inwards C, Scully SP, Janknecht R. 2004. hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins. Clin Orthop 426:64-68.
18. Furuya K, Nakamoto T, Shen ZJ, Tsuji K, Nifuji A, Hirai H, Noda M. 2000. Overexpression of Cas-interacting zinc finger protein (CIZ) suppresses proliferation and enhances expression of type I collagen gene in osteoblast-like MC3T3E1 cells. Exp Cell Res 261:329-335.
19. Hinohara S, Satake N, Sekine K, Kaneko Y. 1998. Abnormalities of the FHIT transcripts in osteosarcoma and Ewing sarcoma. Jpn J Cancer Res 89:887-894.
20. Hunger SP, Zhong CH. 2002. Cryptic t(12;19) in ALL with lineage switch to AML creates two new E2A fusion proteins. Blood 100:529A.
21. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT. 1992. Fusion of the Leucine Zipper Gene Hlf to the E2A Gene in Human Acute B-Lineage Leukemia. Science 257:531-534.
22. Kamps MP, Wright DD, Lu Q. 1996. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene 12:19-30.
23. Lefstin JA, Yamamoto KR. 1998. Allosteric effects of DNA on transcriptional regulators. Nature 392:885-888.
24. Lessnick SL, Braun BS, Denny CT, May WA. 1995. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene 10:423-431.
25. Lessnick SL, Dacwag CS, Golub TR. 2002. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1:393-401.
26. Mackay JP, Crossley M. 1998. Zinc fingers are sticking together. Trends Biochem Sci 23:1-4.
27. Mao X, Miesfeldt S, Yang H, Leiden JM, Thompson CB. 1994. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J Biol Chem 269:18216-18222.
28. Martini A, La Starza R, Janssen H, Bilhou-Nabera C, Corveleyn A, Somers R, Aventin A, Foa R, Hagemeijer A, Mecucci C, Marynen P. 2002. Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. Cancer Res 62:5408-5412.
29. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R, Denny CT. 1993. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13:7393-7398.
30. McWhirter JR, Goulding M, Weiner JA, Chun J, Murre C. 1997. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1. Development 124:3221-3232.
31. Meissner M, Lopato S, Gotzmann J, Sauermann G, Barta A. 2003. Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins. Exp Cell Res 283:184-195.
32. Monica K, Lebrun DP, Dedera DA, Brown R, Cleary ML. 1994. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: Fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 14:8304-8314.
33. Nakamoto T, Yamagata T, Sakai R, Ogawa S, Honda H, Ueno H, Hirano N, Yazaki Y, Hirai H. 2000. CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases. Mol Cell Biol 20:1649-1658.
34. Nakamoto T, Shiratsuchi A, Oda H, Inoue K, Matsumura T, Ichikawa M, Saito T, Seo S, Maki K, Asai T, Suzuki T, Hangaishi A, Yamagata T, Aizawa S, Noda M, Nakanishi Y, Hirai H. 2004. Impaired spermatogenesis and male fertility defects in CIZ/Nmp4-disrupted mice. Genes Cells 9:575-589.
35. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML. 1990. Chromosomal Translocation-T(1-19) Results in Synthesis of A Homeobox Fusion Messenger-Rna That Codes for A Potential Chimeric Transcription Factor. Cell 60:535-545.
36. Ohno T, Rao VN, Reddy ES. 1993. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res 53:5859-5863.
37. Olsen RJ, Hinrichs SH. 2001. Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins. Oncogene 20:1756-1764.
38. Shah R, Alvarez M, Jones DR, Torrungruang K, Watt AJ, Selvamurugan N, Partridge NC, Quinn CO, Pavalko FM, Rhodes SJ, Bidwell JP. 2004. Nmp4/CIZ regulation of matrix metalloproteinase 13 (MMP-13) response to parathyroid hormone in osteoblasts. Am J Physiol Endocrinol Metab 287:E289-E296.
39. Shen ZJ, Nakamoto T, Tsuji K, Nifuji A, Miyazono K, Komori T, Hirai H, Noda M. 2002. Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts. J Biol Chem 277:29840-29846.
40. Spector DL. 1993. Macromolecular domains within the cell nucleus. Annu Rev Cell Biol 9:265-315.
41. Takahashi A, Higashino F, Aoyagi M, Yoshida K, Itoh M, Kyo S, Ohno T, Taira T, Ariga H, Nakajima K, Hatta M, Kobayashi M, Sano H, Kohgo T, Shindoh M. 2003. EWS/ETS fusions activate telomerase in Ewing's tumors. Cancer Res 63:8338-8344.
42. Thompson AD, Teitell MA, Arvand A, Denny CT. 1999. Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells. Oncogene 18:5506-5513.
43. Thunyakitpisal P, Alvarez M, Tokunaga K, Onyia JE, Hock J, Ohashi N, Feister H, Rhodes SJ, Bidwell JP. 2001. Cloning and functional analysis of a family of nuclear matrix transcription factors (NP/NMP4) that regulate type I collagen expression in osteoblasts. J Bone Miner Res 16:10-23.
44. Torrungruang K, Alvarez M, Shah R, Onyia JE, Rhodes SJ, Bidwell JP. 2002a. DNA binding and gene activation properties of the Nmp4 nuclear matrix transcription factors. J Biol Chem 277:16153-16159.
45. Torrungruang K, Shah R, Alvarez M, Bowen DK, Gerard R, Pavalko FM, Elmendorf JS, Charoonpatrapong K, Hock J, Rhodes SJ, Bidwell JP. 2002b. Osteoblast intracellular localization of Nmp4 proteins. Bone 30:931-936.
46. Triezenberg SJ, Kingsbury RC, Mcknight SL. 1988. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev 2:718-729.
47. Wolfe SA, Nekludova L, Pabo CO. 2000. DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct 29:183-212.
48. Yang L, Embree LJ, Tsai S, Hickstein DD. 1998. Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem 273:27761-27764.
49. Yang L, Chansky HA, Hickstein DD. 2000a. EWS[middle dot]Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. J Biol Chem 275:37612-37618.
50. Yang L, Embree LJ, Hickstein DD. 2000b. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol Cell Biol 20:3345-3354.
51. Yoshihara T, Inaba T, Shapiro LH, Kato JY, Look AT. 1995. E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF. Mol Cell Biol 15:3247-3255.